AFP and metabolic dysfunction-associated steatotic liver disease: These differences included AA patients at presentation (1) being older, (2) having increased incidences of modifiable metabolic risk factors, e.g., diabetes/dyslipidemia and NAFLD, (3) having a higher incidence of gallstones, (4) having larger HCCs and higher AFP values.